CD200, an immunoglobulin superfamily membrane glycoprotein, is expressed in a number of B cell lymphoproliferative disorders, including primary mediastinal large B cell lymphoma, but not diffuse large ...

Lymphomas account for approximately 12% of total mediastinal tumors and represent heterogeneous histological subtypes 1. Lymphomas involving the mediastinum exhibit a wide age range, occurring in both ...

Patients with a type of cancer known as primary mediastinal B-cell lymphoma who received infusions of chemotherapy, but who did not have radiation therapy to an area of the thorax known as the ...

PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification. There is uncertainty about the relevance and especially the optimal ...

Immune checkpoint inhibitor therapies (ICIs) pembrolizumab and nivolumab show high overall response rates (ORR) in the treatment of relapsed or refractory (R/R) primary mediastinal B-cell lymphoma ...

Non-Hodgkin's lymphoma is a group of cancers that start in lymphocytes -- your immune system’s infection-fighting white blood cells. Doctors divide it into types based on the kind of lymphocyte each ...

Please provide your email address to receive an email when new articles are posted on . The FDA expanded the approval of pembrolizumab to include the treatment of adult and pediatric patients with ...

Please provide your email address to receive an email when new articles are posted on . A 57-year-old female nonsmoker presented with cough and left-sided chest pain. She underwent a chest radiograph ...

PURPOSE: Primary mediastinal B-cell lymphoma (PMBL) is recognized as a separate disease entity in the REAL classification. There is uncertainty about the relevance and especially the optimal ...

The approval was based on data from the KEYNOTE-170 study, a multicenter, open-label, single-arm trial that included 53 patients with relapsed or refractory PMBCL. The Food and Drug Administration ...